Recital 26, Regulation (EU) 2026/2348

In force

The application for the renewal of the approval of the active substance calcium carbide was submitted on 30 August 2016 and the rapporteur Member State informed the co-rapporteur Member State, the Commission and the Authority on 30 September 2016 that it had assessed the admissibility of the application pursuant to Article 3 of Implementing Regulation (EU) No 844/2012, and in particular its completeness and timeliness, and concluded that it was admissible. The application has been made public by the Authority. On 11 January 2024, the rapporteur Member State submitted the draft renewal assessment report to the Authority, which conducted a public consultation on it between 23 September and 22 November 2024. On 23 April 2025, the Authority requested additional information for the purposes of the renewal assessment pursuant to Article 13(3) of Implementing Regulation (EU) No 844/2012 and the applicant replied on 26 May 2025 that it is not able to provide additional data and requested the conclusion to be based on the already available data. The Authority estimates that it will be able to finalise its conclusion for calcium carbide by the end of October 2026, and as the Commission will need time to adopt the ensuing risk management decisions, the duration of the extension of the approval period should be set at 14 months, until 31 January 2028.

  • celex=32012R0844